3rd Quarter - Report
ALEXION PHARMACEUTICALS, INC. for ALEXION PHARMACEUTICALS, INC.
Income
—
Expenses
$322,689
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
ANDUFA
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEIGH OWANO | — |
| VANESSA PROCTER | — |
Copyright/Patent/Trademark CPT
Intellectual Property Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEIGH OWANO | — |
| VANESSA PROCTER | — |
Medicare/Medicaid MMM
Medicare Inpatient Hospital Reimbursement Medicaid Reform Third party payments for co-pays and premium assistance Medicare Part D Coinsurance
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEIGH OWANO New | — |
| VANESSA PROCTER | — |
Health Issues HCR
Orphan Drug Act Medicaid Reform Drug Pricing Medicare Part D coinsurance DRG Reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEIGH OWANO New | — |
| VANESSA PROCTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.